ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-ß copathology. (2019)
Attributed to:
The UK GENetic Frontotemporal dementia Initiative (UK GENFI)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.dadm.2019.01.010
PubMed Identifier: 30949567
Publication URI: http://europepmc.org/abstract/MED/30949567
Type: Journal Article/Review
Volume: 11
Parent Publication: Alzheimer's & dementia (Amsterdam, Netherlands)
ISSN: 2352-8729